Drawing for XIAMETER

USPTO serial 76697129

XIAMETER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PARADEWELAI, BENJI YUEN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XIAMETER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scot A. Duvall

Scot A. Duvall Middleton Reutlinger2500 Brown & Williamson Tower401 S. Fourth AvenueLouisville, KY 40202

Goods and services

ClassDescriptionStatusFirst use
001Silicone used in the manufacture of chemicals, fluids, resins, and plastics used in the medical and pharmaceutical field; silicones for medical and pharmaceutical purposes, namely, silicones for use in the manufacture of skin care products; silicones for medical purposes, namely, silicones for use in the manufacture of non-adherent dressings, burn treatment gauzes, cavity wound dressings, skin barriers, and burn masks; silicone fluids, namely, antifoams and antifoam silicone emulsions; silicone fluids, namely, silicone dispersions for use with cutting edges, needles, and biomedical devices; chemicals used in industry, namely, silicone-based topical excipients for use in the manufacture of drug delivery, skin care products, and pharmaceutical products; liquid silicone rubbers for use in the manufacture of O-rings, stoppers, and closures in medical devices; liquid silicone rubbers for use in the manufacture of medical device implants; silicone-containing pourable elastomer resins for use in the manufacture of drug matrixes for pharmaceutical applications; silicone-containing elastomer resins for use in the manufacture of medical prostheses and pressure cushions; silicone resins for use in the manufacture of pharmaceutical and biopharmaceutical tubing; silicones for use in the manufacture of dental hygiene products and dental impressions; silicone-based adhesives for use in assembling and sealing medical device components in the manufacture of medical devices; silicone-based adhesives for use in encapsulating and sealing electrical components in the manufacture of medical devices; Silicone used in the manufacture of chemicals, fluids, resins, and plastics used in the implantation of medical devices in the bodyACTIVE—
005Silicones for medical and pharmaceutical purposes, namely, silicone-containing chemicals, fluids, resins, and plastics for use in the treatment of scars; silicones for medical and pharmaceutical purposes, namely, silicone-containing chemicals, fluids, resins, and plastics for use in the treatment of burns; silicones for medical and pharmaceutical purposes, namely, silicone-containing chemicals, fluids, resins, and plastics for use in the treatment of wounds; silicone-based medical adhesives for use in the attachment of wound dressings, prosthetics, transdermal drug delivery systems, and scar therapy medical devices to the body; silicone-based medical adhesives for pharmaceutical topical or transdermal applicationsACTIVE—
010Silicone elastomer coatings sold as integral components of a wide variety of implantable medical devices; silicone-based molded tubing assemblies for biopharmaceutical and pharmaceutical fluid transfer; silicone-based medical grade tubing for medical and pharmaceutical drug administration purposesACTIVE—
017Liquid rubbers for medical applications, namely, liquid silicone rubbers for use in fabric coating for medical devices; Liquid rubbers for medical applications, namely liquid silicone rubbers for use in mesh coating for medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 9, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 9, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 14, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2011EX1GSOU EXTENSION 1 GRANTED—
Jun 10, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 7, 2011EXT1SOU EXTENSION 1 FILED—
Jun 7, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 12, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 3, 2010ALIEASSIGNED TO LIE—
Aug 23, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 18, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 16, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 16, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 16, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 28, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 30, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2009DOCKASSIGNED TO EXAMINER—
May 8, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
May 4, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance